semaglutide fda news The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 compounding semaglutide news FDA alerts

After Your Injection: Proper Aftercare and Storage Immediately after needle withdrawal, apply gentle pressure to the injection site with a sterile gauze pad for 5 to 10 secondslight bleeding or oozing is normal and requires no special treatment

If you want maximum simplicity during weight loss treatment, a long-acting reversible contraceptive removes the need for daily timing coordination with your semaglutide or tirzepatide injection

^Zhang S, Wang C, Zhong W, Kemp AH, Guo M, Killpartrick A

Reduced Systemic Inflammation GLP-1 receptors on immune cells and adipose tissue suppress CRP, TNF-, and IL-6

M., Pronzato, M